This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.

Psoriatic arthritis (PsA) is often misunderstood, and those misconceptions can make it harder for people to recognize symptoms, seek care, or understand what living with the condition is really like.

The approval was based on results from the POETYK PsA-I and POETYK PsA-II Phase III clinical trials.

In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in ...

European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults: Princeton, New Jersey Monday, May 11, 2026, 15:00 Hrs [IST ...

Millions of people living with arthritis may unknowingly be eating foods that increase inflammation, joint stiffness, and ...

Alert EU Backs New Oral Option in Psoriatic Arthritis The European Medicines Agency has endorsed expanded use of Sotyktu for psoriatic arthritis, recommending approval after clinical trials showed ...

A 27-year-old woman from Colchester living with psoriatic arthritis has become the face of a national campaign to raise ...

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like arthritis, IBD, allergies, and more.

AbbVie (ABBV) has built a solid reputation among passive income-focused investors, backed by an impressive 54-year streak of ...

Vyome strikes deal with Impetis Biosciences, opening a $57 billion market opportunity: Our Bureau, Bengaluru Wednesday, May 13, 2026, 14:30 Hrs [IST] Vyome Holdings, Inc. has inke ...

AbbVie today announced the presentation of new data across its gastroenterology portfolio at the 2026 Digestive Disease Week (DDW) Annual Meeting, May 2-5 in Chicago. AbbVie will present 18 abstracts, ...